Their exact conclusion was «an increase in serum calcium concentrations is associated with an increased risk of type 2 diabetes in individuals
at high cardiovascular risk».
These results, published online recently in the journal Antiviral Therapy, are the first to confirm an association between low vitamin D levels and a measure
of higher cardiovascular risk in people with HIV.
REDUCE - IT is the first multinational cardiovascular outcomes study evaluating the effect of prescription pure EPA therapy, or any triglyceride - lowering therapy, as an add - on to statins in patients with
high cardiovascular risk who, despite stable statin therapy, have elevated triglyceride levels (150 - 499 mg / dL).
The trial included 501 patients with atherosclerotic cardiovascular disease (ASCVD) and elevated LDL cholesterol (> 70mg / ml) despite maximum tolerated statin therapy and patients without ASCVD but with
high cardiovascular risk conditions such as diabetes and familial hypercholesterolaemia in whom LDL cholesterol was > 100mg / dl despite maximally tolerated statin therapy.
Further aspects, which could partly
explain higher cardiovascular risk for women with T2DM compared with diabetic men, were described in a cross-sectional study, which documented in vitro sex differences in fibrin structure function (288).
PREDIMED, one of the largest interventional dietary trials, randomized more than 7,000 men and women at
high cardiovascular risk into different diet groups and followed them for years.
High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real - world analysis of statin - treated patients
with high cardiovascular risk and well - controlled low - density lipoprotein cholesterol [abstract].
Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects
at high cardiovascular risk.
Inclisiran lowers low - density lipoprotein (LDL; «bad») cholesterol for up to one year in patients with
high cardiovascular risk and elevated LDL cholesterol, according to late - breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
They added that study results are mainly focused on
a high cardiovascular risk population that includes people who can obtain the most benefits from this diet intervention.
The PREDIMED study published in the New England Journal of Medicine in 2013 demonstrated that among those with
high cardiovascular risk, a Mediterranean diet supplemented with extra-virgin olive oil and nuts reduced the incidence of major cardiovascular events (stroke, heart attack, and death).
Among persons at
high cardiovascular risk, a Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced the incidence of major cardiovascular events.
In a multicenter trial in Spain, we randomly assigned participants who were at
high cardiovascular risk, but with no cardiovascular disease at enrollment, to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet (advice to reduce dietary fat).
Back in 2013 a study was published in the New England Journal of Medicine titled «Primary Prevention of Cardiovascular Disease with a Mediterranean Diet» stating through results of this study, which included over 7000 participants per group — «among persons at
high cardiovascular risk, a Mediterranean diet supplemented with extra virgin olive oil or nuts reduced * the incidence of major cardiovascular events.»
Kar P, Laight D, Rooprai HK, Shaw KM, Cummings M. Effects of grape seed extract in Type 2 diabetic subjects at
high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Our findings are consistent with those of prior observational studies of the cardiovascular protective effects of the Mediterranean diet, olive oil, and nuts; smaller trials assessing effects on traditional cardiovascular risk factors and novel risk factors, such as markers of oxidation, inflammation, and endothelial dysfunction; and studies of conditions associated with
high cardiovascular risk — namely, the metabolic syndrome and diabetes.
Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at
high cardiovascular risk.
Separate research showed that eating just one ounce of walnuts a day may decrease cardiovascular risk, and among those at
high cardiovascular risk, increased frequency of nut consumption significantly lowers the risk of death.
Diabetic Medicine, May 2009, 26 (5): 526ï ¿ 1/2 531, «Effects of grape seed extract in Type 2 diabetic subjects at
high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity»
«What I think the study underlines is the need to consider the severity of ADHD symptoms and the option of non-stimulant treatments for children with
high cardiovascular risk.
3 Baseline data for the Torpedo study23 before random allocation — management of patients with
high cardiovascular risk or established cardiovascular disease in 40 general practices and 20 Aboriginal community controlled health services for the 12 months to May 2012